Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ANIMAL STEM CELL THERAPY INDUSTRY
2.1 Summary about Animal Stem Cell Therapy Industry
2.2 Animal Stem Cell Therapy Market Trends
2.2.1 Animal Stem Cell Therapy Production & Consumption Trends
2.2.2 Animal Stem Cell Therapy Demand Structure Trends
2.3 Animal Stem Cell Therapy Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Dogs
4.2.2 Horses
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Veterinary Hospitals
4.3.2 Research Organizations
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Dogs
5.2.2 Horses
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Veterinary Hospitals
5.3.2 Research Organizations
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Dogs
6.2.2 Horses
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Veterinary Hospitals
6.3.2 Research Organizations
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Dogs
7.2.2 Horses
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Veterinary Hospitals
7.3.2 Research Organizations
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Dogs
8.2.2 Horses
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Veterinary Hospitals
8.3.2 Research Organizations
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Dogs
9.2.2 Horses
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Veterinary Hospitals
9.3.2 Research Organizations
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 MediVet Biologic
10.1.2 VETSTEM BIOPHARMA
10.1.3 J-ARM
10.1.4 Celavet
10.1.5 Magellan Stem Cells
10.1.6 U.S. Stem Cell
10.1.7 Cells Power Japan
10.1.8 ANIMAL CELL THERAPIES
10.1.9 Animal Care Stem
10.1.10 Cell Therapy Sciences
10.1.11 VetCell Therapeutics
10.1.12 Animacel
10.1.13 Aratana Therapeutics
10.2 Animal Stem Cell Therapy Sales Date of Major Players (2017-2020e)
10.2.1 MediVet Biologic
10.2.2 VETSTEM BIOPHARMA
10.2.3 J-ARM
10.2.4 Celavet
10.2.5 Magellan Stem Cells
10.2.6 U.S. Stem Cell
10.2.7 Cells Power Japan
10.2.8 ANIMAL CELL THERAPIES
10.2.9 Animal Care Stem
10.2.10 Cell Therapy Sciences
10.2.11 VetCell Therapeutics
10.2.12 Animacel
10.2.13 Aratana Therapeutics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT